Business Wire

MONUMENT-RE

Share

Monument Re Signs Agreement to Sell Robein Leven N.V.

Monument Re announced today that, subject to regulatory approval, it has entered into an agreement to sell Robein Leven N.V. and its subsidiary Robein Effectendienstverlening (collectively “Robein”) to Chesnara plc through its existing Netherlands-based platform, the Waard Group. Robein Leven is a closed life insurer domiciled in the Netherlands with traditional and linked savings products, mortgages and annuities.

Both Monument Re and Chesnara are committed to providing continuity of services during the period of transition and will take all steps necessary to prepare for a seamless transfer for policyholders and staff.

Change of control of the companies will follow satisfaction of customary closing conditions, including receipt of regulatory approvals.

Aperghis & Co acted as financial adviser to Monument Re with Simmons and Simmons providing legal counsel.

About Monument Re

Monument Re is a reinsurer and asset consolidator with a proven track record in the acquisition and operation of portfolios or direct insurers in Europe. Monument Re has a presence in Bermuda which has full Solvency II equivalence along with Switzerland. The Monument Re Group also operates through its subsidiaries in Belgium, the Netherlands, Ireland, Isle of Man, Guernsey, and Luxembourg, with branches in Spain, Italy and Germany.

Monument Re is subject to Group Supervision by the Bermuda Monetary Authority.

To learn more, please visit www.monumentregroup.com or contact Fiona Davies at info@monumentregroup.com .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom